Conference Update

EULAR updates its recommendations for managing rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Rheumatology
2 months ago, OP Editor

  1. Smolen S et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020; 79:685–699
  2. Smolen S et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis.2017; 76:960–77.
  3. Van Mulligen et al. Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomized controlled TARA study. Annals of the Rheumatic Disease 2019; 78:746-753.

Tags

Menu Section